Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma

Figure 2

Gene expression of FABP7 in glioma and normal tissues. Comparison of FABP7 mRNA expression levels between glioma and normal tissues. (a) CGGA dataset. (b) TCGA dataset. (c) GSE7696 dataset. (d)GSE4290 dataset. (e) Protein levels of FABP7 in normal tissue by immunohistochemistry based on the HPA website (staining: medium; intensity: moderate; quantity: >75%, patient id 1537). (f) Protein levels of FABP7 in glioma tissue by immunohistochemistry based on HPA website (staining: high; intensity: strong; quantity: >75%, patient id 2790). (g, h) Expression of FABP7 in 10 pairs of glioma and adjacent tissues tested by western blot. (i) Expression of FABP7 in various cancers based on TIMER2.0. T: tumor tissue; A: adjacent tissue.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)